30.11.2017
- In a provisional ruling announced on Nov. 21, the UK’s Competition and Markets Authority (CMA) has found that Canadian pharma Concordia abused its dominant position to overcharge...
15.02.2016
- Major UK drugs firm GlaxoSmithKline (GSK) has been fined more than £37 million by the Competition and Markets Authority (CMA) for anti-competitive behavior relating to generic...
20.06.2013
- European antitrust regulators fined nine drugmakers, including Denmark's Lundbeck, a total of €146 million ($195 million) for blocking the supply of a cheaper anti-depressant to...
03.06.2013
- A European regulator will fine Denmark's Lundbeck and eight other makers of generic drugs for limiting the supply of cheaper medicines, two people with knowledge of the matter said...
19.04.2013
- Britain's competition body accused GlaxoSmithKline of market abuse for striking deals with three generic drugmakers that paid them to delay launching cheap copies of its...
